Canine Adenovirus Type 2-Parainfluenza-Bordetella Bronchiseptica Vaccine, Modified Live Virus, Avirulent Live Culture
153 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
153
Total Reports
11
Deaths Reported
720.0%
Death Rate
Active Ingredients
Canine Adenovirus Type 2-Parainfluenza-Bordetella Bronchiseptica Vaccine, Modified Live Virus, Avirulent Live Culture
Administration Routes
NasalUnknownSubcutaneousOralOtherParenteral
Species Affected
Dog 153
Most Affected Breeds
Retriever - Labrador 17
Terrier - Yorkshire 12
Retriever - Golden 9
Chihuahua 7
Shih Tzu 6
Pit Bull 5
Boxer (German Boxer) 5
Bulldog - French 5
Siberian Husky 5
Crossbred Canine/dog 4
Most Reported Reactions
Vomiting 34
Lethargy (see also Central nervous system depression in 'Neurological') 24
Lack of efficacy - NOS 20
Diarrhoea 20
Cough 19
Other abnormal test result NOS 17
Anaphylaxis 13
Death 10
Pale mucous membrane 9
Lack of efficacy (virus NOS) 9
Lethargy (see also Central nervous system depression in Neurological) 9
Anorexia 8
Outcome Breakdown
Outcome Unknown
73 (47.7%)
Recovered/Normal
37 (24.2%)
Ongoing
32 (20.9%)
Died
11 (7.2%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.